[EN] BRIDGED COMPOUNDS AS AGONISTS OF THE MUSCARINIC M1 AND/OR M4 RECEPTOR<br/>[FR] COMPOSÉS PONTÉS À UTILISER EN TANT QU'AGONISTES DU RÉCEPTEUR MUSCARINIQUE M1 ET/OU M4
申请人:HEPTARES THERAPEUTICS LTD
公开号:WO2019243851A1
公开(公告)日:2019-12-26
This invention relates to compounds that are agonists of the muscarinic M1 and/or M4 receptor and which are useful in the treatment of diseases mediated by the muscarinic M1 and M4 receptors. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula (I) where Y, R1, R2 and R4 are as defined herein.
Controllable Intramolecular Unactivated C(sp3)-H Amination and Oxygenation of Carbamates
作者:Qihang Guo、Xiang Ren、Zhan Lu
DOI:10.1021/acs.orglett.8b03299
日期:2019.2.15
catalyst-controlled intramolecular unactivated C(sp3)-H amination and oxygenation of carbamates merging visible-light photocatalysis and earth-abundant transition metal catalysis have been reported. Useful amino alcohol and diol derivatives could be selectively obtained from readily available tertiary alcohol derivatives. The possible mechanisms have been proposed via a 1,5-HAT process followed by Lewis acid-controlled